Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa

Ocular Adnexal Lymphomas are the first cause of primary ocular malignancies, and among them the most common are MALT Ocular Adnexal Lymphomas. Recently systemic immunotherapy with anti-CD20 monoclonal antibody has been investigated as first-line treatment; however, the optimal management for MALT Oc...

Full description

Bibliographic Details
Main Authors: Ombretta Annibali, Francesca Chiodi, Chiara Sarlo, Magdalena Cortes, Francesco M. Quaranta-Leoni, Carlo Quattrocchi, Antonella Bianchi, Stefano Bonini, Giuseppe Avvisati
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2015/895105

Internet

http://dx.doi.org/10.1155/2015/895105

Similar Items